机译:SARS患者衍生的S和M蛋白人类重组抗体可有效中和SARS冠状病毒的感染性
State Key Laboratory for Infectious Disease Control and Prevention, Institute for Viral Disease Control and Prevention;
State Key Laboratory for Infectious Disease Control and Prevention, Institute for Viral Disease Control and Prevention;
State Key Laboratory for Infectious Disease Control and Prevention, Institute for Viral Disease Control and Prevention;
State Key Laboratory for Infectious Disease Control and Prevention, Institute for Viral Disease Control and Prevention;
State Key Laboratory for Infectious Disease Control and Prevention, Institute for Viral Disease Control and Prevention;
State Key Laboratory for Infectious Disease Control and Prevention, Institute for Viral Disease Control and Prevention;
State Key Laboratory for Infectious Disease Control and Prevention, Institute for Viral Disease Control and Prevention;
State Key Laboratory for Infectious Disease Control and Prevention, Institute for Viral Disease Control and Prevention;
State Key Laboratory for Molecular Virology, Chinese Center for Disease Control and Prevention, 100 Yingxin Street, Xuanwu District, Beijing 100052, China;
State Key Laboratory for Infectious Disease Control and Prevention, Institute for Viral Disease Control and Prevention;
State Key Laboratory for Molecular Virology, Chinese Center for Disease Control and Prevention, 100 Yingxin Street, Xuanwu District, Beijing 100052, China;
State Key Laboratory for Molecular Virology, Chinese Center for Disease Control and Prevention, 100 Yingxin Street, Xuanwu District, Beijing 100052, China;
State Key Laboratory for Infectious Disease Control and Prevention, Institute for Viral Disease Control and Prevention;
SARS-CoV; Phage display; Human antibody;